WebJan 9, 2024 · Background SWOG 0809 is the only prospective study of adjuvant chemotherapy followed by chemoradiation focusing on margin status in patients with … WebMethods We did this open-label, phase 3 study (SWOG S0819) at 277 sites in the USA and Mexico. We randomly assigned (1:1) eligible patients with treatment-naive stage IV NSCLC to receive paclitaxel (200 mg/m²; every 21 days) plus carboplatin (area under the curve of 6 by modified Calvert formula; every 21 days) or carboplatin plus paclitaxel
Cetuximab plus carboplatin and paclitaxel with or without …
WebMay 11, 2014 · Purpose The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown. S0809 was … WebMay 11, 2015 · The SWOG S0809 trial showed that adjuvant capecitabine and gemcitabine followed by CRT in resected GBC was feasible and effective, but it did not compare this … lawn courte
[PDF] SWOG S0809: A Phase II Intergroup Trial of Adjuvant …
WebMar 13, 2024 · The management of non-muscle invasive bladder cancer (NMIBC) starts with the resection of all visible disease, with a focus on the existing standard of care, … WebApr 1, 2024 · Read the Interactive Bulletin PDF. Download the app via the Apple Store, Google Play, or Amazon. ... SWOG S0809 (NCT00789958) The SWOG S0809 was a single … WebMar 31, 2015 · Abstract. The Lung Master Protocol (Lung-MAP, S1400) is a groundbreaking clinical trial designed to advance the efficient development of targeted therapies for squamous cell carcinoma (SCC) of the lung. There are no approved targeted therapies specific to advanced lung SCC, although The Cancer Genome Atlas project and similar … kalamazoo airport flight arrivals